Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCNA | P12004 | 5/20 | 0.35 |
| ▸ | THRB | P10828 | 5/20 | 0.35 |
| ▸ | THRA | P10827 | 4/20 | 0.35 |
| ▸ | CACNA1B | Q00975 | 3/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6845200 | 0.91 | PCNA (0.37) | PCNATHRBTHRACACNA1BSCN9A | |
| SCHEMBL24894639 | 0.87 | THRA (0.40) | PCNATHRBTHRACACNA1BSCN9A | |
| SCHEMBL1526096 | 0.84 | THRB (0.39) | PCNATHRBTHRALMNACYP2D6 | |
| SCHEMBL12584373 | 0.83 | ITGB3 (0.44) | PCNATHRBTHRASCN9ALMNA | |
| SCHEMBL6845190 | 0.83 | ITGB3 (0.44) | PCNATHRBTHRASCN9ALMNA | |
| SCHEMBL8189234 | 0.77 | THRB (0.44) | PCNATHRBTHRALMNACYP2D6 | |
| SCHEMBL17612212 | 0.77 | ITGB3 (0.43) | PCNATHRBTHRASCN9ALMNA | |
| SCHEMBL1526077 | 0.76 | THRB (0.36) | PCNATHRBTHRALMNACYP2D6 | |
| SCHEMBL16124515 | 0.75 | KLK5 (0.43) | PCNATHRBTHRASCN9ALMNA | |
| SCHEMBL16124513 | 0.72 | ITGB3 (0.46) | PCNATHRBTHRASCN9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230018014-A1 | NOVEL COMPOUNDS AND FORMULATIONS | PRO-AL MEDICO-TECHNOLOGIES, INC. | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230018014-A1 | NOVEL COMPOUNDS AND FORMULATIONS | TNNI3, TNNT2, TNNC1 | PCNA 4851/4885THRB 15/4885THRA 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.